Krishna C. Bulusu

Oncology R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

BEACON: predicting side effects and therapeutics outcomes to drugs by Bridging knowlEdge grAph with CONtextual language model.

BEACON: predicting side effects and therapeutics outcomes to drugs by Bridging knowlEdge grAph with CONtextual language model.

Journal: bioRxiv : the preprint server for biology

Published: February 09, 2026

PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.

PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.

Journal: Research square

Published: February 06, 2026

Bimodality in pan-cancer proteomics reveals new opportunities for biomarker discovery.

Bimodality in pan-cancer proteomics reveals new opportunities for biomarker discovery.

Journal: Genome biology

Published: December 01, 2025

Indoor positioning with multi-domain CSI-based deep attention networks for MIMO wireless systems.

Indoor positioning with multi-domain CSI-based deep attention networks for MIMO wireless systems.

Journal: NPJ wireless technology

Published: June 04, 2025

DDI-GPT: Explainable Prediction of Drug-Drug Interactions using Large Language Models enhanced with Knowledge Graphs.

DDI-GPT: Explainable Prediction of Drug-Drug Interactions using Large Language Models enhanced with Knowledge Graphs.

Journal: bioRxiv : the preprint server for biology

Published: December 23, 2024

PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.

PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 22, 2024

Author Correction: Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors.

Author Correction: Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors.

Journal: NPJ systems biology and applications

Published: August 08, 2024

Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.

Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.

Journal: Journal of translational medicine

Published: June 03, 2024

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers.

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers.

Journal: NPJ precision oncology

Published: January 24, 2024

Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.

Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.

Journal: Cancer discovery

Published: April 04, 2023

Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA.

Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 12, 2022

Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors.

Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors.

Journal: NPJ systems biology and applications

Published: August 22, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026